Gabelli Funds’s AVANIR PHARMACEUTICALS, INC CL A AVNR Stock Holding History

Gabelli Funds’s Portfolio AVNR Stock Details AVNR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q1	–	Sell	-1,986,189	Closed	-$33.7M	–	1124
2014 Q4	$33.7M	Buy	+1,986,189	New	+$27.9M	0.16%	193

Gabelli Funds's AVNR Position: Q1 2015 in Review

Gabelli Funds sold out of AVANIR PHARMACEUTICALS, INC CL A (AVNR) in Q1 2015, closing a stake of 1,986,189 shares — an estimated $33.7M sold.

Gabelli Funds first reported a position in AVNR in Q4 2014 and held it in 1 quarter. The position peaked at $33.7M in Q4 2014. 0 funds tracked by Wall St. Rank hold AVNR as of Q1 2015.

Gabelli Funds reported no remaining AVANIR PHARMACEUTICALS, INC CL A position as of Q1 2015 after selling out during the quarter.
Gabelli Funds sold 1,986,189 AVANIR PHARMACEUTICALS, INC CL A shares in Q1 2015, an estimated $33.7M.
Gabelli Funds first reported a position in AVANIR PHARMACEUTICALS, INC CL A in Q4 2014 and held it in 1 quarter.
Gabelli Funds's AVANIR PHARMACEUTICALS, INC CL A position peaked at $33.7M in Q4 2014.
0 funds tracked by Wall St. Rank held AVANIR PHARMACEUTICALS, INC CL A as of Q1 2015.

Based on Gabelli Funds's 13F filing for Q1 2015, filed 1 May 2015.